Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive entities : Orange save search
Proof Positive & Members of its Nationwide Autism Wellbeing Alliance Celebrate Global Commitment to the Autism Community on International Day of Happiness
Published: 2024-03-07 (Crawled : 12:30) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
|
| O: 0.79%
H: 0.78%
C: 0.78%
day positive international global nationwide
Lyndra Therapeutics Announces Positive Data from Pivotal Phase 3 Study with Oral Weekly Risperidone (LYN-005) for Schizophrenia
Published: 2024-01-04 (Crawled : 20:00) - biospace.com/
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 0.37%
H: 1.38%
C: 0.82%
lyn-005 positive schizophrenia therapeutics study
Vibrato Medical Announces Positive Results for Early Feasibility Study of Wearable, Non-Invasive Therapeutic Ultrasound to Treat Chronic Limb-Threatening Ischemia (CLTI)
Published: 2023-11-01 (Crawled : 21:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
|
| O: -1.44%
H: 0.0%
C: -1.88%
positive treat medical results study
Eagle Pharmaceuticals Announces Positive Type C Meeting with FDA for EA-114, an Estrogen Receptor Antagonist Used in the Treatment of Metastatic Breast Cancer in Post-Menopausal Women
Published: 2023-08-29 (Crawled : 11:00) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
|
| O: 1.76%
H: 0.0%
C: 0.0%
EGRX | $4.505 2.62% 2.55% 140K
|
Health Technology
|
| O: 0.49%
H: 3.15%
C: 2.79%
ea-114 fda breast positive cancer treatment pharmaceuticals women meeting
Dr. Steven Gundry's Gundry MD Polyphenol Dark Spot Diminisher Celebrates 1,000+ Positive Reviews
Published: 2023-08-14 (Crawled : 13:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
|
| O: 0.63%
H: 0.0%
C: 0.0%
positive
NevGold Provides Positive Update On Limousine Butte: New Geological Model Identifies High Priority 2023 Drill Targets
Published: 2023-07-06 (Crawled : 12:00) - globenewswire.com
CGAU | News | $6.07 0.17% 0.0% 370K
|
Mining, Quarrying, and Oil and ...
|
| O: -0.33%
H: 0.17%
C: -2.5%
MUX | $11.04 1.38% 0.0% 910K
|
Non-Energy Minerals
|
| O: -0.72%
H: 0.58%
C: -1.59%
FCX 4 | $50.16 0.68% -0.06% 16M
|
Non-Energy Minerals
|
| O: -2.27%
H: 0.84%
C: -0.99%
positive update
Caliway Announces Positive Data from CBL-0201EFP Phase 2-Stage 1 Study of CBL-514 in Treating Moderate to Severe Cellulite
Published: 2023-06-28 (Crawled : 12:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
| Email alert
Add to watchlist
cbl-0201 positive study
Beyond Cancer™ Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the American Association for Cancer Research (AACR) 2023 Annual Meeting
Published: 2023-04-19 (Crawled : 13:00) - globenewswire.com
XAIR | $1.175 -8.2% -8.94% 610K
|
Technology Services
|
| O: -0.65%
H: 2.45%
C: -2.29%
beyond association tumors positive cancer research preclinical meeting therapy
Moleculin Announces Presentation of Positive Pharmacokinetics and Tissue-Organ Distribution Data Demonstrating High Antitumor Activity of Annamycin in Preclinical Cancer Models
Published: 2023-04-18 (Crawled : 18:00) - prnewswire.com
MBRX | News | $4.59 7.24% 6.75% 50K
|
Health Technology
|
| O: 1.6%
H: 73.68%
C: -9.79%
distribution presentation positive cancer preclinical
Panavance Therapeutics Announces Positive Preclinical Data Demonstrating GP-2250 Single-Agent and Combination Activity for the Treatment of Ovarian Cancer
Published: 2023-04-17 (Crawled : 14:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
| Email alert
Add to watchlist
gp-2250 positive cancer treatment preclinical therapeutics
BriaCell Presents Positive Data Demonstrating Survival and Clinical Benefits in Advanced Metastatic Breast Cancer at the 2023 AACR
Published: 2023-04-17 (Crawled : 12:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 2.78%
H: 3.51%
C: 2.43%
breast positive cancer benefits
BioCorRx Announced Interim Positive Safety and Pharmacokinetic Results of Phase 1 Clinical Trial at 4th Annual NIH HEAL Initiative Investigator Meeting
Published: 2023-03-07 (Crawled : 21:00) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
| Email alert
Add to watchlist
BICX | $1.47 201.91% 200
|
Health Care and Social Assistan...
| Email alert
Add to watchlist
meeting trial positive results phase 1
The Worldwide Ready to Drink Tea and Coffee Industry is Expected to Reach $140.7 Billion by 2027: Shifting Preference Toward Organic Product Variants to Create Positive Outlook
Published: 2023-01-23 (Crawled : 18:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
| Email alert
Add to watchlist
organic expected ready positive
Oramed to Host Webinar Highlighting Detailed Safety and Efficacy Data from Its Positive Phase 2 Clinical Trial of ORMD-0801 for NASH
Published: 2022-11-09 (Crawled : 14:00) - prnewswire.com
ORMP | $2.19 -6.01% -6.39% 240K
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: -5.05%
ormd-0801 trial positive nash
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
Published: 2022-10-13 (Crawled : 11:00) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
|
| O: -4.1%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.78%
H: 0.0%
C: 0.0%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.64%
H: 3.35%
C: 2.92%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.67%
H: 0.0%
C: 0.0%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: -2.2%
H: 6.32%
C: 4.76%
trial positive
The Return of the Denny's Orange Blossom Classic Presented by Ready Life Continues to Produce a Positive Impact
Published: 2022-09-07 (Crawled : 14:00) - prnewswire.com
XYF | News | $3.78 -0.26% 0.0% 4.9K
|
Finance
|
| O: -4.24%
H: 6.64%
C: 2.21%
impact life ready positive
Nephros Announces Preliminary Results for Quarter Ended June 30, 2022 and Projects Positive Net Cash Flow in 12 Months
Published: 2022-07-06 (Crawled : 12:20) - biospace.com/
NEPH | $2.05 3.02% 2.93% 8.2K
|
Health Technology
|
| O: 7.59%
H: 1.28%
C: -5.13%
flow positive
LYNPARZA® (olaparib) Receives Positive Opinion From EU CHMP as Adjuvant Treatment for Germline BRCA-Mutated, HER2-Negative High-Risk Early Breast Cancer
Published: 2022-06-27 (Crawled : 11:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
|
| O: 0.62%
H: 0.0%
C: -0.35%
MRK | $125.23 -0.11% 0.0% 6M
|
Health Technology
|
| O: -0.16%
H: 2.7%
C: 1.3%
lynparza treatment chmp positive cancer her2- her2
PROpel Phase III Trial Positive Results of LYNPARZA® (olaparib) Plus Abiraterone in 1st-line Metastatic Castration-resistant Prostate Cancer Published in New England Journal of Medicine Evidence
Published: 2022-06-21 (Crawled : 12:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
| Email alert
Add to watchlist
lynparza propel trial plus positive results cancer prostate cancer
Genentech Announces Positive Data from Broad Blood Cancer Portfolio at European Hematology Association Annual Meeting
Published: 2022-06-10 (Crawled : 08:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
| Email alert
Add to watchlist
blood positive cancer
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.